Menu
Back to User profile » Dr Jianxing Xiang
Papers published by Dr Jianxing Xiang:
Targeted Sequencing Facilitated Diagnosis of an Uncommon Patient Harboring Both Multiple Primary and Intrapulmonary Metastatic Lung Cancer: A Case Report
Li H, Dong S, Zhang D, Guo Z, Li C, Xiang J, Zou X, Yan L, Sun Y, Li W
OncoTargets and Therapy 2021, 14:3455-3459
Published Date: 26 May 2021
Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
He Y, Ma X, Chen K, Liu F, Cai S, Han-Zhang H, Hou T, Xiang J, Peng J
Cancer Management and Research 2020, 12:1621-1630
Published Date: 4 March 2020
Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Xu H, Shen J, Xiang J, Li H, Li B, Zhang T, Zhang L, Mao X, Jian H, Shu Y
Cancer Management and Research 2019, 11:6343-6351
Published Date: 9 July 2019
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Ma Y, Mao X, Zhang L, Zhang T, Wu D
Drug Design, Development and Therapy 2019, 13:1809-1817
Published Date: 23 May 2019
Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
Liu Z, Wu L, Cao J, Yang Z, Zhou C, Cao L, Wu H, Shen H, Jin M, Zhang Y, Mao X, Xiang J, Ma K, Li B, Zhang T, Hu Y
OncoTargets and Therapy 2018, 11:7323-7331
Published Date: 23 October 2018
The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients
Cao L, Long L, Li M, Yang H, Deng P, Mao X, Xiang J, Li B, Zhang T, Hu C
OncoTargets and Therapy 2018, 11:2637-2646
Published Date: 8 May 2018